Moderna’s cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled
MarketWatch ·
A ‘sell-the-news reaction’? The experimental treatment helped prevent the return of cancer or death in melanoma patients by 42% after two years.
Publication and source information
- Platform
- NewsTiVi
- Source
- MarketWatch
- Published
- 10/22/2026, 8:14:00 PM
- Country
- United States
The headline and summary are supplied by the publisher. Read the full report on the source website.
Contact: info@newstivi.com